Project Grant HT94252510139
Award Date
7/1/25
Completion Date
6/30/29
Dollars Obligated
$2.7M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
West Hollywood, CA 90048, USA
Similar Awards
This $4,089,970 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Cedars-Sinai Medical Center to investigate spatial reprogramming of tumor immune microenvironments through preoperative radiotherapy and immune checkpoint inhibition in HER2 negative breast cancer. The award will fund basic, translational, and clinical research over 4 years from September 2023 to August 2027 to develop new treatments,...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, provides $876,686.00 to Cedars-Sinai Medical Center to conduct research on "Unraveling Genomic Rearrangements in EGF-Mutant NSCLC Mechanisms Underlying Resistance to Tyrosine Kinase Inhibitors." The research, with a performance period from May 15, 2025, to May 14, 2028, will focus on exploring innovative approaches to preventing, diagnosing, and...
This $1,251,673.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Cedars-Sinai Medical Center on August 1, 2023. The grant will fund research aimed at re-engineering the intratumoral myeloid-macrophage compartment to enhance the response to radiation and immunotherapy in triple-negative breast cancer. The three-year project will be performed at Cedars-Sinai's facilities in West Hollywood, CA. As a leading...
The U.S. Department of Defense awarded a $1,000,000.00 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development program (CFDA 12.420) to evaluate short- and long-term systemic anti-tumor immunity following combined radiation and immunotherapy in triple-negative breast cancer. This 4-year research project, which commenced on Sep 15, 2023 and is scheduled for completion by Sep 14, 2027, aims to investigate medical solutions for transforming healthcare for...
The Defense Health Agency awarded Cedars-Sinai Medical Center a $667,963 Project Grant to "INVESTIGATE EXTRACELLULAR MATRIX PROTEINS LOCAL AND SYSTEMIC ROLE IN PROMOTING SOFT TISSUE SARCOMA" over the period of 09/01/2023 to 08/30/2025. This award was made under the Military Medical Research and Development (CFDA 12.420) federal grant program, which supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public. As a...
This Project Grant award of $1,252,479.00 from the Defense Health Agency supports Cedars-Sinai Medical Center's biomedical research to re-engineer the intratumoral myeloid-macrophage compartment and enhance the response to radiation and immunotherapy in triple-negative breast cancer. The award falls under the Military Medical Research and Development program (CFDA 12.420), which focuses on transforming health care for Service Members and the public through innovative and impactful research....
This $729,690 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports metabolic intervention research to halt pancreatic cancer at Cedars-Sinai Medical Center in West Hollywood, California. The project will run from November 1, 2024 to October 31, 2027, investigating innovative approaches to disease prevention, diagnosis, treatment, and management of pancreatic cancer. As a prominent research institution,...
The Department of Defense's Defense Health Agency awarded a $1,164,294 Project Grant to Cedars-Sinai Medical Center on September 15, 2024 under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund a 4-year project to correlate prostate-specific membrane antigen (PSMA) expression with molecular profiles in prostate cancer. Cedars-Sinai, a non-profit hospital and academic medical center, will conduct this biomedical research to advance understanding of...
This $598,130 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research on the determinants of lung cancer-associated cachexia at Cedars-Sinai Medical Center in West Hollywood, CA. The award period is from February 15, 2025 to February 14, 2027. The funding will enable Cedars-Sinai, a prominent nonprofit academic medical center, to conduct sophisticated scientific investigations...
Cedars-Sinai Medical Center will receive $501,000 through a two-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support the medical center's research project "CD44 Enhances Efficacy of the Chimeric Antigen Receptor T-Cell Therapy Against Prostate Cancer." Through this funding, Cedars-Sinai researchers will investigate using CD44 to improve the effectiveness of CAR T-cell therapy in treating...